Navigation Links
Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories
Date:4/20/2011

hed to foster the collaboration.

Dr. Gwan Sun Lee, Chief Executive Officer of Hanmi Pharmaceuticals states: "This collaboration is an important strategic decision for Hanmi Pharmaceuticals as this will facilitate our company to further expand our oncology franchise to China and other Asian Countries."

Dr. Jeewoong Son, Chief Medical Officer and Senior Vice-President of Research and Development, states: "The profile of KX01 is excellent and this compound will complement our oncology business strategy very well. We are excited to have the opportunity to work with the Kinex team to take this compound through the various development phases to obtain its approval in Korea and China to help Asian patients with cancer."

Hanmi Pharmaceuticals is one of leading pharmaceutical companies in Korea. Hanmi Pharmaceuticals has established a strong Research and Development team in Korea and one of their focuses is in the field of oncology.  

"We have selected Hanmi Pharmaceuticals as our Asian partner because we are impressed by their strong commitment to Research and Development.  We are also impressed by their business growth strategy", states Chief Executive Officer of Kinex Pharmaceuticals, Dr. Allen Barnett, who was credited for his effort in the discovery and development of Claritin when he was working at the Schering-Plough Research Institute.

Dr. David Hangauer, Senior Vice-President of Research and Development states: "Kinex Pharmaceuticals is delighted to have a chance to work with this well established research and development team. Their experience in oncology will be critical in helping to drive this project to regulatory approval."

"We are impressed by the clinical research commitments of Hanmi Pharmaceuticals. Together with our internal programs, we are confident that our joint effort will expedite the realization of the full potential of KX01," states Chief Medical Officer of Kinex Pharmaceuticals,
'/>"/>

SOURCE Kinex Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Merrimack Pharmaceuticals Announces that Recruitment is Open in a Phase 1 Combination Study of MM-111 with Multiple Treatment Regimens in HER2 Positive Patients
2. Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 36th Annual Health Care Conference
4. Sagent Pharmaceuticals Upsizes and Prices Initial Public Offering
5. Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis
6. Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection
7. Bexion Pharmaceuticals Receives Outstanding Biotech Innovation Award
8. Sigma-Tau Pharmaceuticals Announces Approval for New Manufacturing Process for ONCASPAR® (Pegaspargase) Primary Ingredient
9. Keryx Biopharmaceuticals Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical
10. Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl
11. Amylin Pharmaceuticals Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014  Aethlon Medical, Inc. (OTCQB:AEMD), announced today that ... approximately $3.3 million at a price of $0.30 per ... focused investor. Each unit consists of one common share ... warrant. Each whole warrant entitles the holder to acquire ... a period of five years from closing.  ...
(Date:11/26/2014)...  Cohen, Placitella & Roth, PC is investigating ... Nymox Pharmaceutical Corporation ("Nymox" or "Company") (NASDAQ: ... 31, 2011 through November 2, 2014 ("Class Period").  ... its officers and directors publically disseminated materially false ... and 20(a) of the Securities Exchange Act of ...
(Date:11/26/2014)... Nov. 26, 2014 Lexicon Pharmaceuticals, Inc. ... completion of previously announced concurrent financing transactions resulting ... and estimated offering expenses, Lexicon anticipates net proceeds ... transactions consisted of: , a public ... to a registration statement that has been declared ...
Breaking Medicine Technology:Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3
... 13-14, 2011, in Beijing, China, the Food and Drug Law ... drug law, regulation and policy in China and the United ... Commissioner, State Food and Drug Administration, Ambassador Zhang Yesui, Chinese ... at the meeting. Several U.S. government officials are expected to ...
... CHICAGO, Dec. 15, 2010 Allscripts MyWay ... -- deeming the Electronic Health Record (EHR) software capable ... use measures required to qualify for funding under the ... under the Drummond Group,s Electronic Health Records Office of ...
Cached Medicine Technology:Food and Drug Law Institute to Hold Historic Conference on U.S.-China Food and Drug Law 2Allscripts MyWay™ Electronic Health Record Receives ONC-ATCB Certification by Drummond Group 2Allscripts MyWay™ Electronic Health Record Receives ONC-ATCB Certification by Drummond Group 3Allscripts MyWay™ Electronic Health Record Receives ONC-ATCB Certification by Drummond Group 4Allscripts MyWay™ Electronic Health Record Receives ONC-ATCB Certification by Drummond Group 5
(Date:11/28/2014)... Dr. Paul Vitenas, one of the most awarded ... Holiday Event for those in the area that would like to ... & Glow will take place on December 11, 2014, from 6:00 ... heart of Houston at 4208 Richmond Ave. , “We want ... will come and celebrate the season with us on December 11, ...
(Date:11/28/2014)... Written and narrated by award winning author ... “The Happiest Man In the World: Life Lessons From ... and why Project C.U.R.E. came to be. , Raised in ... the Reverend Richard W. Jackson, Dr. Jackson exceeded his goal ... realized that he wasn’t happy. Prompted by this realization, James ...
(Date:11/28/2014)... Kramer HealthDay Reporter , THURSDAY, ... the kitchen, through cooking classes or at home, may make ... recent review. Cooking programs and classes for children seem ... the new research. And, although the review didn,t look at ... programs might help children develop long-lasting healthy habits. ...
(Date:11/28/2014)... An inventor and dental assistant from Kent, Wash., ... and it was almost impossible to reach. "This gave me ... , The patent-pending Access Light allows for easier use of ... the mouth, as well as avoids harm to the lips, ... use and clean, it also helps prevent cross-contamination. , The ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 More ... have now been filed in a New Jersey ... implants, Bernstein Liebhard LLP reports. , A ... County Superior Court reflects the filing of 2,160 ... hip stems, which were voluntarily recalled on July ...
Breaking Medicine News(10 mins):Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:Want Kids to Eat Better? Get Them Cooking 2Health News:Want Kids to Eat Better? Get Them Cooking 3Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 2Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 3
... techniques, the Chinese Tai chi and various relaxation techniques would ... on May 28 by the Rajayoga Foundation of Brahmakumaris of ... of the Medical wing of the foundation and a ... of physical ailments by discovering the spiritual potential of the ...
... research conducted by the King’s Collage London, analysed health reports of ... in 2003 with those who took part// in the 1991 war, ... ,The study findings that are published in The Lancet report ... Syndrome" in British male armed forces personnel deployed to the 2003 ...
... government is planning to bifurcate the Health and Family ... Health Services//. This step is thought to allow for ... Welfare Minister R Ashok said that the step was ... abuse the system. Initially the government will ask 23 ...
... conducted by the rheumotologists in the University of South ... form of Adkins-type diet for weight loss, has no ... the earlier findings conducted in animal studies. This finding ... issue of the journal Osteoporosis International. Low carbohydrate diets ...
... least six Reang refugees staying in camps in North Tripura ... HIV positive, official sources today here said. // ... in Kanchanpur subdivision by the state health department., ,The ... were found affected by AIDS and 12 as HIV positive, ...
... Ltd today said it would raise 16 million dollar through ... ,The company would allot 16,000 FCCBs of 1,000 ... listed on the Singapore Stock Exchange, Ankur Drugs informed the ... would be allotted 14,000 FCCBs while 1,000 FCCBs would be ...
Cached Medicine News:Health News:Good News For The Obese People 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 12 mm....
Medicine Products: